Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Mar 20;41(9):1649-1651.
doi: 10.1200/JCO.22.02605. Epub 2023 Jan 20.

Circulating Tumor DNA in the Blood: A New Frontier in Primary CNS Lymphoma?

Affiliations
Editorial

Circulating Tumor DNA in the Blood: A New Frontier in Primary CNS Lymphoma?

Christian Grommes. J Clin Oncol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The following represents disclosure information provided by the author of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/authors/author-center.

Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).

Christian Grommes

Honoraria: Scribbs

Consulting or Advisory Role: BTG, Kite/Gilead, Ono Pharmaceutical

Other Relationship: Bayer, Bristol Myers Squibb, Pharmacyclics, Celgene

No other potential conflicts of interest were reported.

Comment on

  • Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain Lymphomas.
    Mutter JA, Alig SK, Esfahani MS, Lauer EM, Mitschke J, Kurtz DM, Kühn J, Bleul S, Olsen M, Liu CL, Jin MC, Macaulay CW, Neidert N, Volk T, Eisenblaetter M, Rauer S, Heiland DH, Finke J, Duyster J, Wehrle J, Prinz M, Illerhaus G, Reinacher PC, Schorb E, Diehn M, Alizadeh AA, Scherer F. Mutter JA, et al. J Clin Oncol. 2023 Mar 20;41(9):1684-1694. doi: 10.1200/JCO.22.00826. Epub 2022 Dec 21. J Clin Oncol. 2023. PMID: 36542815 Free PMC article.

References

    1. Grommes C, DeAngelis LM: Primary CNS lymphoma. J Clin Oncol 35:2410-2418, 2017 - PMC - PubMed
    1. Mendez JS, Ostrom QT, Gittleman H, et al. : The elderly left behind-changes in survival trends of primary central nervous system lymphoma over the past 4 decades. Neuro Oncol 20:687-694, 2018 - PMC - PubMed
    1. Bataille B, Delwail V, Menet E, et al. : Primary intracerebral malignant lymphoma: Report of 248 cases. J Neurosurg 92:261-266, 2000 - PubMed
    1. Han CH, Batchelor TT: Diagnosis and management of primary central nervous system lymphoma. Cancer 123:4314-4324, 2017 - PubMed
    1. Mutter JA, Alig SK, Esfahani MS, et al. : Circulating tumor DNA profiling for detection, risk stratification, and classification of brain lymphomas. J Clin Oncol 41:1684-1694, 2023 - PMC - PubMed

MeSH terms

Substances